A retrospective study to evaluate efficacy of switching from ranibizumab to aflibercept treatment in patients with wet age-related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 25 Jul 2017 New trial record